We are thrilled to have been granted £750k to prevent feeding tube misplacements. This grant brings propels us one step closer to helping end an NHS ‘Never Event’ after securing £750,000 through a mix of private investment and matched funding from the British Business Bank’s Future Fund.
The £750,000 of funding we have secured will enable us to manufacture the device in the UK and initiate commercialisation beginning in Q2 of 2021. The investment will also be used to obtain FDA approval ahead of the US expansion being led by NGFS’s team in Chicago, Illinois.
As important to our advancement in technology is our aim to increase awareness too. Med-Tech Innovation has featured this report in the latest news for the medical device industry and helps us to get our message out.
